News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,735 Results
Type
Article (40076)
Company Profile (271)
Press Release (661388)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205111)
Career Advice (2021)
Deals (35538)
Drug Delivery (97)
Drug Development (81244)
Employer Resources (172)
FDA (16210)
Job Trends (14913)
News (346488)
Policy (32647)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49779)
ALS (88)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (127)
Approvals (16215)
Artificial intelligence (253)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (279)
Cancer (2260)
Cardiovascular disease (174)
Career advice (1689)
Career pathing (30)
CAR-T (152)
Cell therapy (427)
Cervical cancer (19)
Clinical research (66112)
Collaboration (841)
Compensation (529)
Complete response letters (19)
COVID-19 (2604)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2203)
Decentralized trials (2)
Denatured (20)
Depression (43)
Diabetes (271)
Diagnostics (6389)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86763)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112929)
Executive appointments (729)
FDA (17470)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (752)
Gene editing (106)
Generative AI (19)
Gene therapy (302)
GLP-1 (711)
Government (4429)
Grass and pollen (4)
Guidances (65)
Healthcare (18839)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (140)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16544)
IRA (42)
Job creations (3665)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (474)
Leadership (17)
Legal (7944)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (67)
Medical device (13387)
Medtech (13392)
Mergers & acquisitions (19536)
Metabolic disorders (685)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1922)
NextGen: Class of 2025 (6548)
Non-profit (4492)
Now hiring (39)
Obesity (362)
Opinion (208)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (149)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (46)
People (57637)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20613)
Phase II (29122)
Phase III (21680)
Pipeline (1197)
Policy (141)
Postmarket research (2564)
Preclinical (8773)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5953)
Recruiting (65)
Regulatory (22346)
Reports (46)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (132)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3631)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (30)
Vaccines (688)
Venture capitalists (43)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (184)
Last 7 days (882)
Last 30 days (2646)
Last 365 days (32999)
2025 (10708)
2024 (35331)
2023 (40181)
2022 (51291)
2021 (55837)
2020 (54157)
2019 (46647)
2018 (35128)
2017 (32227)
2016 (31631)
2015 (37709)
2014 (31454)
2013 (26500)
2012 (28777)
2011 (29431)
2010 (27528)
Location
Africa (721)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (38050)
Australia (6232)
California (6142)
Canada (2012)
China (523)
Colorado (267)
Connecticut (275)
Delaware (147)
Europe (81772)
Florida (910)
Georgia (206)
Idaho (58)
Illinois (537)
India (26)
Indiana (308)
Iowa (11)
Japan (161)
Kansas (105)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (893)
Massachusetts (4578)
Michigan (220)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1726)
New Mexico (28)
New York (1744)
North Carolina (966)
North Dakota (8)
Northern California (2684)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1376)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (23)
South Dakota (1)
Southern California (2306)
Tennessee (101)
Texas (910)
United States (23148)
Utah (180)
Virginia (145)
Washington D.C. (62)
Washington State (554)
West Virginia (3)
Wisconsin (54)
701,735 Results for "greenwich biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Greenwich LifeSciences Provides Global Update on FLAMINGO-01
April 4, 2025
·
16 min read
Press Releases
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
March 28, 2025
·
4 min read
Press Releases
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
March 17, 2025
·
8 min read
Press Releases
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
April 2, 2025
·
9 min read
Press Releases
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
January 27, 2025
·
6 min read
Press Releases
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
January 29, 2025
·
5 min read
Lone Star Bio
Greenwich LifeSciences Set to Join Russell 2000 Index Again
Greenwich LifeSciences, Inc. announced that it is set to join the Russell 2000 and Russell 3000 Indexes at the conclusion of the Russell indexes annual reconstitution, effective after the US markets open on July 1, 2024, according to a list of additions updated as of June 21, 2024.
June 26, 2024
·
5 min read
Press Releases
Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01
January 14, 2025
·
8 min read
Press Releases
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
January 23, 2025
·
8 min read
Press Releases
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
February 11, 2025
·
11 min read
1 of 70,174
Next
